Robert Heimer, Ph.D.

Roles:

• Professor, Yale School of Public Health

• Member, Executive Committee, CIRA

• Director, Office of International Training, CIRA

• Investigator, Development Core, CIRA

• Investigator, Interdisciplinary Research Methods Core, CIRA

• Investigator, Law, Policy and Ethics Core, CIRA

Biography:

Currently, Dr. Heimer's major research efforts include both field-based prevention work and laboratory investigations of disease transmission risks. The field-based work concentrates on the scientific evaluation of prevention programs serving drug users. These include syringe exchange, hepatitis vaccination, and overdose prevention. The laboratory work concentrates on the virological assessment of the risk of syringe sharing and other drug injection behaviors that may transmit HIV-1 and hepatitis C virus. His recent publications include studies on both of these topics.

CIRA Affiliated Projects:

• Administrative Supplement to TB-AIDS ICOHRTA

• CIRA/St. Petersburg Research Collaborative Project

• Developing a Scientific and Methodological Center for Research and Facilitation Efficiency Improvement of Organizations Engaged in HIV Prevention in the Russian Federation

• Environmental Factors in HIV Transmission among Suburban IDUs

• Environmental Factors in HIV Transmission among Suburban IDUs (Diversity Supplement)

• Evaluating the Effects of Expanded Hours for Syringe Exchange Programs in Connecticut

• HIV Transmission in Russia Through Liquid Drug Injection

• Illicit Opiate Use in Maine

• Impediments to Syringe Exchange Use by Minority Women

• Influences on HIV Prevalence and Service Access among IDUs in Russia and Estonia

• Integrating Sex and Drug Related HIV Risk and Transmission (Diversity Supplement)

• International Feasibility Study of Pharmacy-Based HIV Prevention: St. Petersburg

• Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in Vitro

• Pilot Intervention Research: Brief Care-based HIV Prevention for Newly Diagnosed Men

• Simulating HIV-1 Transmission Risks among IDUs

• Syringe Exchange Based Hepatitis B Vaccination of IDUs